Emyria Ltd
ASX:EMD
Emyria Ltd
ASX:EMD
Price:
0.047
AUD
-6%
Market Closed
Market Cap:
AU$37.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hangzhou Kaierda Welding Robot Co Ltd
SSE:688255
|
CN |
|
Scholium Group PLC
LSE:SCHO
|
UK |
|
R
|
Ranhill Utilities Bhd
KLSE:RANHILL
|
MY |
|
M
|
Mast Energy Developments PLC
LSE:MAST
|
UK |
|
Centuria Capital Group
ASX:CNI
|
AU |
|
A
|
Amerant Bancorp Inc
NYSE:AMTB
|
US |
Emyria Ltd
Other Items
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Emyria Ltd
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Emyria Ltd
ASX:EMD
|
Other Items
AU$95k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Other Items
-AU$39.1m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Other Items
-AU$88m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Other Items
AU$52.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vita Life Sciences Ltd
ASX:VLS
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Emyria Ltd
Glance View
Emyria Ltd. is a healthcare technology and services company. The firm provides care for its patients through its clinics gathering real-world-evidence (RWE) insights in relation to therapies, such as cannabinoid-based medicines and drug development. Its evidence-based drug development program (EMD-003) is focused on mental health and EMD-004 is focused on irritable bowel syndrome (IBS). The Company’s subsidiaries include Emyria Clinical Network Pty Ltd and Openly Care Inc.
EMD Intrinsic Value
LOCKED
See Also
What is Emyria Ltd's Other Items?
Other Items
95k
AUD
95k
AUD
Based on the financial report for Jun 30, 2025, Emyria Ltd's Other Items amounts to 95k AUD.
